FIELD: medicine.
SUBSTANCE: recombinant polypeptide is proposed for inducing an immune response against Neisseria meningitidis in a mammal, an immunogenic composition comprising it, and a recombinant nucleic acid encoding said polypeptide. Recombinant polypeptide consists of the amino acid sequence shown in SEQ ID NO: 71, wherein the first twenty amino acid residues of the sequence do not contain cysteine. Immunogenic composition for inducing an immune response against Neisseria meningitidis in a mammal includes an effective amount of said polypeptide and a pharmaceutically acceptable carrier.
EFFECT: expression level of said recombinant polypeptide is greater than the expression level of the corresponding non-mute type of the sequence of SEQ ID NO: 70.
15 cl, 9 dwg, 34 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS FOR USING THEM | 2017 |
|
RU2739504C2 |
NON-LIPIDISED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS | 2011 |
|
RU2546873C2 |
IMMUNOGENIC COMPOSITION FOR NEISSERIA MENINGITIDIS (OPTIONS) | 2014 |
|
RU2662968C2 |
COMPOSITIONS OF NEISSERIA MENINGITIDIS AND METHODS FOR PREPARATION THEREOF | 2016 |
|
RU2723045C2 |
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS | 2018 |
|
RU2780425C2 |
MENINGOCOCCAL fHBP POLYPEPTIDES | 2009 |
|
RU2475496C2 |
MENINGOCOCCAL fHBP POLYPEPTIDES | 2012 |
|
RU2567003C2 |
VACCINES FOR SEROGROUP X MENINGOCOCCUS | 2013 |
|
RU2644340C2 |
VERSIONS OF FACTOR N-BINDING PROTEIN AND METHODS OF USE THEREOF | 2015 |
|
RU2714248C2 |
STABLE COMPOSITIONS OF ANTIGENS Neisseria meningitidis rLP2086 | 2011 |
|
RU2580620C2 |
Authors
Dates
2018-09-04—Published
2013-03-06—Filed